← Leaderboards
Kai I Cheang
Virginia Commonwealth University
$962,451
Attributed
$962,451
Total exposure
12
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $251.5K · FY2006–10$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$962,451 · 12
By mechanism
K23$632,635 · 1
M01$306,919 · 9
P41$22,897 · 2
Top collaborators
No co-investigators on record.
Most similar at Virginia Commonwealth University
Same institution · by research overlap
- John E Nestler$6,116,076
- Maria J Iuorno$249,365
- Paulina A Essah$945,136
Others in their field
Top investigators on “Institution”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,187,810,557
- Leonard Freedman · Leidos Biomedical Research, Inc.$835,530,754
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Jeffrey P Krischer · University Of South Florida$566,554,288
- Bambra Strokes · Ppd Development Lp$526,656,217
Research focus
InstitutionResearch PersonnelWomanInsulin ResistanceSyndromeAffectInsulin SensitivityInsulinInositolInositolphosphoglycanUnited States National Institutes Of HealthComputer Retrieval Of Information On Scientific Projects DatabaseResourcesMediator Of Activation ProteinFundingPolycystic Ovary SyndromeGrantSourceIntravenous Glucose Tolerance TestInsulin MediatorsBody Weight DecreasedObesityImpaired Glucose ToleranceAnovulation
Grant awards (16)
Insulin and the Polycystic Ovary Syndrome$133,194
K23 · FY2010 · HD · contact PI
INSULIN AND THE POLYCYSTIC OVARY SYNDROMEUWEIGHT REDUCTION STUDY$32,858
M01 · FY2010 · RR · contact PI
INSULIN-STIMULATED RELEASE OF D-CHIRO-INOSITOL-CONTAINING INOSITOLPHOSPHOGLYCAN$11,261
P41 · FY2010 · RR · contact PI
ORAL CONTRACEPTIVES IN METABOLIC SYNDROME$2,899
M01 · FY2010 · RR · contact PI
Insulin and the Polycystic Ovary Syndrome$130,705
K23 · FY2009 · HD · contact PI
INSULIN AND THE POLYCYSTIC OVARY SYNDROMEUWEIGHT REDUCTION STUDY$55,518
M01 · FY2009 · RR · contact PI
ORAL CONTRACEPTIVES IN METABOLIC SYNDROME$53,651
M01 · FY2009 · RR · contact PI
INSULIN-STIMULATED RELEASE OF D-CHIRO-INOSITOL-CONTAINING INOSITOLPHOSPHOGLYCAN$11,636
P41 · FY2009 · RR · contact PI
Insulin and the Polycystic Ovary Syndrome$126,706
K23 · FY2008 · HD · contact PI
INSULIN AND THE POLYCYSTIC OVARY SYNDROMEUWEIGHT REDUCTION STUDY$88,363
M01 · FY2008 · RR · contact PI
ORAL CONTRACEPTIVES IN METABOLIC SYNDROME$32,235
M01 · FY2008 · RR · contact PI
Insulin and the Polycystic Ovary Syndrome$122,863
K23 · FY2007 · HD · contact PI
ORAL CONTRACEPTIVES IN METABOLIC SYNDROME$22,825
M01 · FY2007 · RR · contact PI
Insulin and the Polycystic Ovary Syndrome$119,167
K23 · FY2006 · HD · contact PI
ORAL CONTRACEPTIVES IN METABOLIC SYNDROME$14,544
M01 · FY2006 · RR · contact PI
Tissue factor polymorphisms in postmenopausal women$4,026
M01 · FY2004 · RR